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At Risk for Huntington's Disease
HD is a genetically caused brain disorder that causes uncontrollable bodily movements and robs
people's ability to walk, talk, eat, and think. The final result is a slow, ugly death. Children of parents
with HD have a 50-50 chance of inheriting the disease. There is no cure or treatment.
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The search for Huntington's disease treatments is
indeed ‘rocket science’ – and we can all help build the
rocket
For people facing Huntington’s disease and other devastating, untreatable
conditions, the powerful wish for a cure can conjure up the image of an
elated scientist bursting from a laboratory and declaring “Eureka!”
However, it is unlikely a treatment for HD will emerge in this way.
We often misunderstand scientific progress, as explained in an essay in the
May 16, 2015, edition of The New York Times by prominent physicist
Leonard Mlodinow, Ph.D.
“Why do we reduce great discoveries to epiphany myths?” asked the subheadline for Dr. Mlodinow’s online article, which was titled “It Is, in Fact,
Rocket Science.”
“The mythical stories we tell about our heroes are always more romantic
and often more palatable than the truth,” Dr. Mlodinow writes. “But in
science, at least, they are destructive, in that they promote false
conceptions of the evolution of scientific thought.”
From Isaac Newton to Charles Darwin to Stephen Hawking, we have
oversimplified the process of discovery, Dr. Mlodinow explains. Rather
than the eureka moments popularized in books and the media – like the
apple falling on Newton’s head – these scientists’ discoveries involved
years of hard work and questioning of assumptions, including their own.
Thus, Dr. Mlodinow reminds us that breakthroughs result from the
cumulative build-up of many moments of discovery by scientists past and
present.
He thus underscores a crucial point for the Huntington’s disease
community: finding treatments will necessarily involve a collective effort
by scientists and volunteers in research studies and clinical trials.
“Even if we are not scientists, every day we are challenged to make
judgments and decisions about technical matters like vaccinations,
financial investments, diet supplements and, of course, global warming,”
Dr. Mlodinow points out. “The myths can seduce one into believing there
is an easier path, one that doesn’t require such hard work.”
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We in the HD community must all play our part in the quest for
treatments.
A eureka moment deflated
As a carrier of the deadly HD mutation who watched his mother succumb
to the disease, I have sometimes fallen prey to the seductive scenario
described by Dr. Mlodinow, and even done so in this blog.
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Four years ago this month, I was so excited about Alnylam
Pharmaceuticals’ progress towards a remedy that I posted a picture of
myself holding an Alnylam compound designed to attack HD at its genetic
roots. I wrote that the compound, “the potential cure in my hand,” seemed
magical.
I later made the image my Facebook profile photo.
(See the photo below and click here to read more.)
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Gene Veritas holding the Alnylam compound in 2011 (photo by Dr.
Matthias Kretschmer, Alnylam)
I had perhaps become overconfident about the Alnylam project.
In collaboration with its partners Medtronic and CHDI Foundation, Inc.,
the nonprofit virtual biotech focused on HD treatments, Alnylam was
planning to apply in 2012 for permission to start a clinical trial.
In early 2012, however, Alnylam cut a third of its work force in order to
reduce costs. In May of that year, less than a year after my 2011 visit, the
company shifted its business strategy. It downgraded the HD project and
fired the scientific director in charge
Alnylam chose instead to concentrate on less complex – and perhaps more
profitable – projects to find drugs for other conditions. Alnylam passed on
the responsibility for testing the compound in a human clinical trial to
Medtronic.
To date, Medtronic has announced no plans for a human clinical trial of
the Alnylam compound.
“Medtronic believes the siRNA [gene-silencing] drug-device program
continues to represent an exciting opportunity to combine an innovative
therapeutic strategy with state-of-the-art drug device delivery technology
for Huntington’s disease,” Jack Lemmon, Ph.D., a Medtronic program
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manager, responded in an e-mail to my request for an update on the
project. “Pre-clinical work has generated promising results; however the
therapy research program has been paused since 2013 until partnerships
can be established allowing us to sustain the research. At this time, it is
premature to discuss timeframes, but we hope to continue work to find a
treatment for this devastating neurodegenerative disease.”
Shots on goal
I am concerned that the project runs the risk of entering a not uncommon
limbo, which one former director of the National Institutes of Health calls
the “valley of death,” the increasingly difficult transition between
laboratories and clinical trials.
Devising the Alnylam compound involved a significant investment of time,
money, and expertise. In my extensive interviews with Alnylam scientists
in 2011, and even in a conference call with some of those same researchers
after the announcement of the 2012 cutback, they expressed enthusiasm
about the promise of the compound.
The Alnylam compound may – or may not – ultimately play a role in the
search for treatments.
Without the Alnylam compound, the HD community would have one less
shot on goal in the critical gene-silencing field.
I am disappointed at the lack of action – much less progress – regarding
the Alnylam compound.
Fortunately for the HD community, one of those shots is scheduled to take
place this year: Isis Pharmaceuticals, Inc., and Roche will start a historic
gene-silencing clinical trial using a different type of drug technology. Other
companies and labs are also focusing on the development of gene-silencing
approaches for HD.
The Alnylam project didn’t meet the expectations of many in the
community. However, it has still provided valuable data from which other
researchers can benefit. I am grateful for Alnylam’s contributions to the
quest for treatments, and I’m crossing my fingers that Medtronic can
resume the project.
I indeed recognize that the path to treatments is not easy. Nor is it straight.
One example of a potentially fortuitous outcome of the Alnylam decision:
the dismissed HD project director, Dinah Sah, Ph.D., now works as the
senior vice president of neuroscience for Voyager Therapeutics, one of the
new companies exploring gene-silencing for HD.
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Dinah Sah, Ph.D., of Voyager Therapeutics (photo by Gene Veritas)
A road paved with cooperation
Enthusiasm is essential, but it must be tempered with the recognition that
scientists need time – and money – to test hypotheses.
It took some two decades to discover the huntingtin gene. At the time of
this breakthrough in 1993, people in the HD community celebrated.
Rightfully so, hope for treatments increased significantly.
Since then, hundreds of researchers from around the globe have published
thousands of scientific papers on HD. Along the way they have identified
hundreds of potential HD drug targets (biological pathways).
From the 1970s until today, thousands of individuals from HD-affected
families have participated in research studies and, more recently, a
growing number of clinical trials.
While many of us are disappointed that successful treatments have not
emerged, we must recognize that the enormous amount of scientific work
regarding HD should contribute – perhaps in ways no one yet knows – to
future progress.
The road to treatments is paved with cooperation, and with the recognition
that multiple drugs may be needed to manage this complex genetic
disorder. (Thus, scientists don’t say “cure” when referring to HD.)
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Cooperation: the HD community out in force at an HDSA Team Hope
Walk (photo by Gene Veritas)
Something larger than ourselves
Our society worships individual “heroes.”
However, in the fight to defeat HD, each participant contributes with his or
her talents and resources: financial donations, scientific expertise,
caregiving, and daily dedication to the cause.
In this long-term commitment, we strive for the well-being of those
beyond ourselves: the children who have yet to develop symptoms, the
future generations of HD families, and other disease communities such as
Alzheimer’s, Parkinson’s, and many conditions even rarer than HD like
dentatorubral-pallidoluysian atrophy, known as DRPLA.
For now, I’ll keep my Facebook profile photo as a symbol of hope governed
by caution.
Yes, defeating HD is rocket science. When, collectively, we have completed
that rocket, we can all ride it together.
(Please remember during HD Awareness Month to donate generously to
the Huntington’s Disease Society of America or the HD cause of your
choice!)
Posted by Gene Veritas at 4:42 PM
Labels: Alnylam , clinical trials , cooperation , cure , gene silencing , heroes ,
Huntington's disease , Isis , Leonard Mlodinow , Medtronic , research studies ,
Roche , science , scientists , treatments , valley of death , volunteers

1 comment:
Sharon said...
Gene, I hope you'll add Help 4 HD International to the list of
HD links on your blog site!
11:08 PM, May 20, 2015
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